Corporate ActionJun 17, 2026, 04:33 PM
NovaBay Warrants Exercised, 22.6M Shares Issued
AI Summary
NovaBay Pharmaceuticals, Inc. amended its October 2025 pre-funded warrants with R01 Fund LP and Framework Ventures IV L.P. to remove certain exercisability restrictions. Following the amendment, both R01 and Framework fully exercised their respective warrants on a cashless basis. This transaction resulted in the issuance of an aggregate of 22,614,600 shares of NovaBay's common stock, bringing the total issued and outstanding shares to 50,449,780 as of June 15, 2026.
Key Highlights
- NovaBay amended October 2025 pre-funded warrants with R01 Fund LP and Framework Ventures IV L.P.
- Amendments removed certain restrictions on warrant exercisability.
- R01 and Framework fully exercised their warrants on a cashless basis.
- NovaBay issued an aggregate of 22,614,600 shares of common stock.
- 24,720 shares were withheld as the cashless exercise price.
- Total issued and outstanding shares reached 50,449,780 as of June 15, 2026.
Price Impact
More from NBY